Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.
Ontology highlight
SUBMITTER: Aikawa NE
PROVIDER: S-EPMC8641960 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA